From the publishers of JADPRO

MPN Resource Center

Advertisement

Tobacco use in the myeloproliferative neoplasms: symptom burden, patient opinions, and care

Last Updated: Thursday, September 9, 2021

According to data from a cross-sectional study of 435 patients with MPNs, current and former smokers experienced a higher total symptom burden (mean 30.4 vs. 27.0, p = 0.07), compared with never smokers. Overall quality of life was also significantly better among never smokers compared with current/former smokers (mean 3.5 vs. 3.9, p = 0.03). 

BMC Cancer
Advertisement
News & Literature Highlights
Advertisement
Advertisement